SFX by Ex Libris Inc.

Title:	The Tumor Suppressor Genes
Source:	Annual Review of Biochemistry [0066-4154] Levine, Arnold yr:1993

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Full text available via Annual Reviews Back Volume Collection

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hartwell, L H H. "Cell cycle control and cancer." Science 266.5192 (1995): 1821-8.
description	2.	Solomon, Benjamin J. "First-line crizotinib versus chemotherapy in ALK-positive lung cancer." The New England journal of medicine 371.23 (2014): 2167-77.
description	3.	Sachdeva, Uma M. "Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma." The Journal of clinical investigation 122.2 (2012): 425-434.
description	4.	Thompson, C B B. "Apoptosis in the pathogenesis and treatment of disease." Science 267.5203 (1995): 1456-62.
description	5.	Hartwell, T A H. "Checkpoints: controls that ensure the order of cell cycle events." Science 246.4930 (1989): 629-634.
description	6.	Elledge, S J J. "Cell cycle checkpoints: preventing an identity crisis." Science 274.5293: 1664-1672.
description	7.	Evan, G I I. "Proliferation, cell cycle and apoptosis in cancer." Nature 411.6835 (2001): 342-348.
description	8.	Kastan, Michael B B. "Cell-cycle checkpoints and cancer." Nature 432.7015 (2004): 316-323.
description	9.	Massagué, J. "G1 cell-cycle control and cancer." Nature 432.7015 (2004): 298-306.
description	10.	Klionsky, Daniel J J. "Autophagy fights disease through cellular self-digestion." Nature 451.7182 (2008): 1069-75.
description	11.	Hengartner, M O O. "The biochemistry of apoptosis." Nature 407.6805 (2000): 770-776.
description	12.	Soda, M. "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer." Nature 448.7153 (2007): 561-6.
description	13.	Snyder, A. "Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma." The New England journal of medicine 371.23 (2014): 2189-2199.
description	14.	Shaw, Alice T. "Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer." The New England journal of medicine 368.25 (2013): 2385-2394.
description	15.	Housman, D E W. "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents." Cell 74.6 (1993): 957-67.
description	16.	Coussens, Lisa M M. "Inflammation and cancer." Nature 420.6917 (2002): 860-7.
description	17.	Sznol, L. "Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer." Clinical cancer research 19.5 (2013): 1021-1034.
description	18.	Rothrock, John F. "OnabotulinumtoxinA for the Treatment of Chronic Migraine." Headache 51.4 (2011): 659-660.
description	19.	Manning, Amity L. "Loss of pRB causes centromere dysfunction and chromosomal instability." Genes & development 24.13 (2010): 1364-76.
description	20.	Albain, K. "Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial." The Lancet 374.9687 (2009): 379-386.